Hydrocortisone eye ointment ointment eye

Страна: Армения

Язык: английский

Источник: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Активный ингредиент:

hydrocortisone (hydrocortisone acetate)

Доступна с:

Arpimed LLC

код АТС:

S01BA02

ИНН (Международная Имя):

hydrocortisone (hydrocortisone acetate)

дозировка:

5mg/g

Фармацевтическая форма:

ointment eye

Штук в упаковке:

aluminium tube 3g

Тип рецепта:

Prescription

Статус Авторизация:

Registered

Дата Авторизация:

2016-07-28

Характеристики продукта

SUMMARY PRODUCT CHARACTERISTIC (SPC)
HYDROCORTISONE EYE OINTMENT
1.1 TRADE NAME
– Hydrocortisone eye ointment
2. COMPOSITION
Each gram contains: ACTIVE INGREDIENT: Hydrocortisone acetate – 5 mg
_For a full list of excipients, see section 6.1. _
3. PHARMACEUTICAL FORM
Ointment.
White or almost white translucent unctuous mass with a slight smell of
ointment.
4
.CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS

Allergic
eye
diseases
(blepharitis,
eyelids
dermatitis,
conjunctivitis,
keratoconjunctivitis)

Inflammatory diseases of the eye anterior section in the absence of
violations
of the integrity of the corneal epithelium (conjunctivitis,
keratoconjunctivitis,
blepharitis)

Chemical and thermal eye burns (after corneal defects complete
healing).
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
For topical administration.
1-2 cm ribbon of ointment should be placed inside the lower
conjunctival sac 2-3
times daily for 1-2 weeks.
Do not use for more than 1-2 weeks without consulting a doctor.
4.3 CONTRAINDICATIONS
• Vaccinia, varicella, or other viral diseases of cornea and
conjunctiva
• Ocular herpes simplex
• Fungal diseases of ocular structures
• Mycobacterial ocular infections
• Acute, untreated purulent bacterial infections
• Hypersensitivity to hydrocortisone or to any of the excipients.
• Intraocular tuberculosis
• Glaucoma
• Trachoma
• Vaccination
• Eye injury
• Children under 18 years of age
_With caution _
Pregnancy and lactation_ _
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
For ocular use only.
Contact lens wear is not recommended during treatment of an ocular
inflammation.
There is no evidence of safety in use in children under two years of
age.
The time interval between the topical instillation of eye drops and
ointment should
not be less than 15 minutes in simultaneous application.
In patients receiving prolonged ophthalmic corticosteroid therapy
(more than 10
days), intraocular pressure should be checked, particularly in
patients with a history
or presence of open-angle